Literature DB >> 8889321

Natural history, clinical evolution, and the host-parasite interaction in New World cutaneous Leishmaniasis.

K Weigle1, N G Saravia.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8889321     DOI： 10.1016/0738-081x(96)00036-3

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN： 0738-081X            Impact factor:   3.541


× No keyword cloud information.
  34 in total

1.  Epidemiological and clinical changes in American tegumentary leishmaniasis in an area of Leishmania (Viannia) braziliensis transmission over a 20-year period.

Authors:  Lara Jirmanus; Marshall J Glesby; Luiz H Guimarães; Ednaldo Lago; Maria Elisa Rosa; Paulo R Machado; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Use of PCR to detect Leishmania (Viannia) spp. in dog blood and bone marrow.

Authors:  R Reithinger; B E Lambson; D C Barker; C R Davies
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  PCR-based diagnosis of acute and chronic cutaneous leishmaniasis caused by Leishmania (Viannia).

Authors:  Kristen A Weigle; Luz Angela Labrada; Caterin Lozano; Cecilia Santrich; Douglas C Barker
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

4.  Evaluation of PCR as a diagnostic mass-screening tool to detect Leishmania (Viannia) spp. in domestic dogs (Canis familiaris).

Authors:  Richard Reithinger; Juan Canales Espinoza; Orin Courtenay; Clive R Davies
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

5.  T-bet, GATA-3, and Foxp3 expression and Th1/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) species.

Authors:  Yira Rosalba Díaz; Ricardo Rojas; Liliana Valderrama; Nancy Gore Saravia
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

6.  Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis.

Authors:  Annette Ives; Catherine Ronet; Florence Prevel; Giulia Ruzzante; Silvia Fuertes-Marraco; Frederic Schutz; Haroun Zangger; Melanie Revaz-Breton; Lon-Fye Lye; Suzanne M Hickerson; Stephen M Beverley; Hans Acha-Orbea; Pascal Launois; Nicolas Fasel; Slavica Masina
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

7.  Sensitivity of Leishmania viannia panamensis to pentavalent antimony is correlated with the formation of cleavable DNA-protein complexes.

Authors:  A Lucumi; S Robledo; V Gama; N G Saravia
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

8.  Association of treatment of American cutaneous leishmaniasis prior to ulcer development with high rate of failure in northeastern Brazil.

Authors:  Alon Unger; Seth O'Neal; Paulo R L Machado; Luiz H Guimarães; Daniel J Morgan; Albert Schriefer; Olívia Bacellar; Marshall J Glesby; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2009-04       Impact factor: 2.345

9.  Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.

Authors:  F Janaina Soares Rocha; Ulrike Schleicher; Jochen Mattner; Gottfried Alber; Christian Bogdan
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

10.  Organization and evolution of two SIDER retroposon subfamilies and their impact on the Leishmania genome.

Authors:  Martin Smith; Frédéric Bringaud; Barbara Papadopoulou
Journal:  BMC Genomics       Date:  2009-05-22       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.